Editorial
Total ankle arthroplasty (TAA) is increasingly utilized in the treatment of end-stage ankle arthritis. Despite a greater understanding of the biomechanics of the ankle and improvements in implant technology and surgical technique, the complication rates after TAA continue to be higher than after arthroplasty of the hip, knee, or shoulder. Review of the TAA literature shows much variation in reporting of follow-up times (as short as 3 months), complications, need for reoperation(s), and outcomes.
The Canadian Orthopedic Foot and Ankle Society (COFAS) Ankle-Arthritis Study Group led the way in addressing these deficiencies by developing standardized reporting systems for adverse events, complications, and reoperations.
1,2 The Editorial Board of Foot & Ankle International (FAI) has discussed the need for more consistent follow-up studies as well as more detailed reporting of complications. Based on these considerations, the following guidelines will be used for submission of TAA papers to FAI.
1. TAA manuscripts must have a minimum of 2-year follow-up for all patients in the study. Complications or implant issues can be reported with shorter follow-up. All repeat surgeries must be documented for all time points from the time of the index TAA. 2. The template (appendix) should be used as a guide for authors in reporting complications resulting in reoperation(s). This is based on the COFAS Ankle Arthritis Study Group coding system for reporting reoperations. Overlap will occur for some of these categories as individual patients may have had more than one reoperation. The intent is to distinguish between different types of complications, resulting in reoperation (instead of simply reporting that a certain number of patients in a study had reoperations). 3. The Editorial Board of FAI also recognizes the need for an international consensus in reporting TAA outcomes. This includes patient-reported outcomes, objective clinical and radiographic measurements, and a system for reporting complications and adverse events. TAA joint registries are also essential so that we can learn from our successes but also from our failures and maintain surveillance to identify nonrandom causes for failure. 4. Repeat surgery can be reported individually or as a series of events. The authors should outline which method was used. Documentation of resource utilization (additional surgery time, days in hospital, or additional clinic visits) for repeat surgery will assist in determining the impact of the complication or repeat surgery. 5. Nonsurgical complications (such as deep vein thrombosis, pulmonary embolism, or infection treated by antibiotics) should also be documented. 
